BioAge Labs (BIOA) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), BioAge Labs had return on equity of -27.1% (up from -50.3%), debt-to-equity of 0.02 (down from 0.03), a current ratio of 14.24 (up from 12.86) and return on assets of -17.8% (up from -25.4%). A current ratio of 14.24 means current assets exceed current liabilities.

BioAge Labs Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Valuation Ratios
P/S Ratio	52.74	-	-	-
P/B Ratio	1.74	0.64	-	-
Price/Tangible Book	1.74	0.64	-	-
Enterprise Value Ratios
EV/Revenue	20.64	-	-	-
Profitability & Returns
Return on Equity (ROE)	-27.09%	-50.35%	-	-
Return on Assets (ROA)	-17.76%	-25.44%	-111.31%	-
Return on Capital Employed (ROCE)	-33.80%	-23.70%	150.10%	-177.10%
Leverage & Solvency Ratios
Debt/Equity	0.02	0.03	-1.31	0.12
Liquidity Ratios
Current Ratio	14.24	12.86	0.43	4.78
Quick Ratio	14.06	12.80	0.37	4.72
Efficiency Ratios
Asset Turnover	0.03	-	-	-
Yield & Distribution Ratios
Earnings Yield	-16.99%	-34.26%	-	-
FCF Yield	-17.36%	-25.00%	-	-
Buyback Yield	-234.99%	-541.23%	-0.06%	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BioAge Labs Financial Ratios

What is BioAge Labs's return on equity?

BioAge Labs's return on equity (ROE) was -27.1% for fiscal 2025 (period ended Dec 31, 2025). It was -50.3% a year earlier.

What is BioAge Labs's debt-to-equity ratio?

BioAge Labs's debt-to-equity ratio was 0.02 for fiscal 2025 (period ended Dec 31, 2025). It was 0.03 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition